Trial Profile
Patient-Reported Psychological Functioning in Natalizumab-Treated Patients with Multiple Sclerosis in US Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2014
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- Sponsors Biogen Idec
- 19 Sep 2014 New trial record